Toll-like receptor 4 polymorphism as pretreatment predictor of response to HCV genotype 3a interferon-based treatment

MLA

Shah Jahan, et al. “Toll-like Receptor 4 Polymorphism as Pretreatment Predictor of Response to HCV Genotype 3a Interferon-Based Treatment.” Future Virology, vol. 12, Dec. 2017, pp. 739–46. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........89614a7f1950d2a7e4c920618ebe53c6&authtype=sso&custid=ns315887.

APA

Shah Jahan, Saba Khaliq, Muhammad Sarfaraz Iqbal, Muhammad Qasim, Muhammad Usman Ghani, Usman Ali Ashfaq, Asma Haque, & Muhammad Shareef Masoud. (2017). Toll-like receptor 4 polymorphism as pretreatment predictor of response to HCV genotype 3a interferon-based treatment. Future Virology, 12, 739–746.

Chicago

Shah Jahan, Saba Khaliq, Muhammad Sarfaraz Iqbal, Muhammad Qasim, Muhammad Usman Ghani, Usman Ali Ashfaq, Asma Haque, and Muhammad Shareef Masoud. 2017. “Toll-like Receptor 4 Polymorphism as Pretreatment Predictor of Response to HCV Genotype 3a Interferon-Based Treatment.” Future Virology 12 (December): 739–46. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........89614a7f1950d2a7e4c920618ebe53c6&authtype=sso&custid=ns315887.